Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables Refunds
Ratios

Merit Medical Systems (MMSI) Accumulated Depreciation & Amortization (2016 - 2025)

Merit Medical Systems' Accumulated Depreciation & Amortization history spans 16 years, with the latest figure at $376.4 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 7.06% year-over-year to $376.4 million; the TTM value through Dec 2025 reached $376.4 million, up 7.06%, while the annual FY2025 figure was $376.4 million, 7.06% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $376.4 million at Merit Medical Systems, roughly flat from $377.8 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $377.8 million in Q3 2025 and bottomed at $265.9 million in Q1 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $323.4 million (2023), against an average of $322.3 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization grew 11.11% in 2021 before it grew 6.15% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $280.6 million in 2021, then increased by 8.07% to $303.3 million in 2022, then grew by 8.5% to $329.0 million in 2023, then rose by 6.86% to $351.6 million in 2024, then increased by 7.06% to $376.4 million in 2025.
  • Per Business Quant, the three most recent readings for MMSI's Accumulated Depreciation & Amortization are $376.4 million (Q4 2025), $377.8 million (Q3 2025), and $371.7 million (Q2 2025).